Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $37.5300 (-2.19%) ($37.4300 - $37.5300) on Mon. Sep. 11, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.13% (three month average) | RSI | 20 | Latest Price | $37.5300(-2.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -2.6% a day on average for past five trading days. | Weekly Trend | HALO declines -3.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(71%) BWX(61%) IVE(55%) XLF(52%) XRT(50%) | Factors Impacting HALO price | HALO will decline at least -1.065% in a week (0% probabilities). VXX(-42%) TBT(-33%) OIH(-28%) UUP(-27%) INDA(-66%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.065% (StdDev 2.13%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.63(-13.06%) | Resistance Level | $41.9 | 5 Day Moving Average | $39.41(-4.77%) | 10 Day Moving Average | $40.97(-8.4%) | 20 Day Moving Average | $41.9(-10.43%) | To recent high | -14.8% | To recent low | 11.3% | Market Cap | $5.129b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |